Atlas Trials

Euthymics BioScience, Inc.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Euthymics BioScience, Inc.

RecordFirmDate
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) (NCT01318434)Euthymics BioScience, Inc.2011-02-01

Track Euthymics BioScience, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.